Dashboard
Manage Tickers

FBRX Forte Biosciences, Inc.

Nasdaq fortebiorx.com


$ 11.75 $ -0.51 (-4.18 %)    

Tuesday, 21-Oct-2025 15:59:41 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 610.29 $ -0.16 (-0.03 %)
DIA $ 469.10 $ 2.20 (0.47 %)
SPY $ 670.98 $ -0.01 (0 %)
TLT $ 91.99 $ 0.45 (0.49 %)
GLD $ 376.61 $ -25.91 (-6.43 %)
$ 11.68
$ 12.30
$ 10.90 x 10
$ 16.06 x 4
$ 11.50 - $ 12.30
$ 4.11 - $ 28.68
114,273
na
145.22M
$ 1.36
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-28-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 03-18-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-16-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 04-23-2020 03-31-2020 10-Q
23 02-27-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 02-27-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-11-2018 03-31-2018 10-Q
31 03-09-2018 12-31-2017 10-K
32 11-08-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-23-2017 03-31-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

forte-biosciences-highlights-fb102s-efficacy-in-celiac-disease-at-tampere-symposium-underscoring-histological-protection-and-symptom-relief-in-phase-1b-study
Forte Biosciences Highlights FB102's Effic...
09/15/2025 13:09:51

Additional data continues to support highly differentiated profile for FB102 in celiac diseaseForte Biosciences, Inc. (www.fort...

guggenheim-initiates-coverage-on-forte-biosciences-with-buy-rating-announces-price-target-of-75
Guggenheim Initiates Coverage On Forte Bio...
08/18/2025 13:03:29

Guggenheim analyst Yatin Suneja initiates coverage on Forte Biosciences (NASDAQ:FBRX) with a Buy rating and announces Price ...

chardan-capital-maintains-buy-on-forte-biosciences-maintains-61-price-target
Chardan Capital Maintains Buy on Forte Bio...
08/15/2025 12:11:19

Chardan Capital analyst Daniil Gataulin maintains Forte Biosciences (NASDAQ:FBRX) with a Buy and maintains $61 price target.

forte-biosciences-q2-eps-096-beats-111-estimate
Forte Biosciences Q2 EPS $(0.96) Beats $(1...
08/14/2025 20:19:34

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
06/25/2025 17:06:36

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
06/25/2025 12:09:37

forte-biosciences-prices-75m-public-offering-of-5630450-common-stock-at-12-and-619606-pre-funded-warrants-at-11999
Forte Biosciences Prices $75M Public Offer...
06/25/2025 05:57:07

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/24/2025 21:06:13

forte-biosciences-announces-proposed-public-offering-no-size-or-amount-disclosed
Forte Biosciences Announces Proposed Publi...
06/24/2025 20:01:45

Forte Biosciences, Inc. (NASDAQ:FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related ...

chardan-capital-maintains-buy-on-forte-biosciences-maintains-61-price-target
Chardan Capital Maintains Buy on Forte Bio...
06/24/2025 12:00:44

Chardan Capital analyst Daniil Gataulin maintains Forte Biosciences (NASDAQ:FBRX) with a Buy and maintains $61 price target.

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
06/23/2025 12:08:57

forte-biosciences-reports-results-in-celiac-disease-trial-paving-way-for-phase-2-in-2026
Forte Biosciences Reports Results in Celia...
06/23/2025 11:20:11

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ:FBRX), a clinical-stage biopharmaceutical company focused on autoimmune an...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/27/2025 17:05:52

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
05/19/2025 12:09:34

why-novavax-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-premarket
Why Novavax Shares Are Trading Higher By A...
05/19/2025 10:34:22

forte-biosciences-q1-eps-137-misses-096-estimate
Forte Biosciences Q1 EPS $(1.37) Misses $(...
05/15/2025 20:09:27

Forte Biosciences (NASDAQ:FBRX) reported quarterly losses of $(1.37) per share which missed the analyst consensus estimate of $...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
04/23/2025 12:06:43

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/07/2025 21:05:55

forte-biosciences-files-for-mixed-shelf-of-up-to-300m
Forte Biosciences Files For Mixed Shelf Of...
03/28/2025 20:50:15

- SEC Filing

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
03/25/2025 17:05:55

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION